PGP and cancer: In 2009, we first described a novel MP mediated “non-genetic” mechanism for the acquisition of multidrug resistance (MDR) in cancer cells, whereby MPs serve as vectors in the intercellular transfer of functional P-gp from MDR donor cells to drug sensitive recipient cells (1).